Cargando…

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing

OBJECTIVE: To determine the most cost-effective screening programme for cervical cancer. DESIGN: Cost-effectiveness analysis from a societal perspective. SETTING: The Netherlands. POPULATION: Dutch women who have not been invited for human papillomavirus (HPV) vaccination. METHODS: We calibrated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rosmalen, J, de Kok, IMCM, van Ballegooijen, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489039/ https://www.ncbi.nlm.nih.gov/pubmed/22251259 http://dx.doi.org/10.1111/j.1471-0528.2011.03228.x

Ejemplares similares

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
por: Burger, E A, et al.
Publicado: (2012)

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study
por: Jansen, EEL, et al.
Publicado: (2020)

Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
por: Sasaki, Yuri, et al.
Publicado: (2017)

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2005)

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
por: Dillner, Joakim, et al.
Publicado: (2008)

Low risk of cervical cancer during a long period after negative screening in the Netherlands
por: van den Akker-van Marle, M E, et al.
Publicado: (2003)

Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort
por: Li, Zhi-Fang, et al.
Publicado: (2022)

Cytology and High-Risk Human Papillomavirus Test for Cervical Cancer Screening Assessment
por: Stuebs, Frederik A., et al.
Publicado: (2022)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan
por: Tshomo, Ugyen, et al.
Publicado: (2017)

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study
por: Palmer, T J, et al.
Publicado: (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing
por: Andreassen, Trude, et al.
Publicado: (2019)

Usefulness of the human papillomavirus DNA chip test as a complementary method for cervical cytology
por: Lee, Rae-Young, et al.
Publicado: (2023)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
por: Matthijsse, Suzette M., et al.
Publicado: (2018)

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support
por: Keane, Adam, et al.
Publicado: (2021)

Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study
por: Hibbitts, S, et al.
Publicado: (2008)

Differences in the risk of cervical cancer and human papillomavirus infection by education level
por: Franceschi, S, et al.
Publicado: (2009)

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
por: Clifford, G M, et al.
Publicado: (2003)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme
por: Sherlaw-Johnson, C, et al.
Publicado: (2004)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions
por: Li, Kemin, et al.
Publicado: (2015)

Prevalence of Human Papillomavirus in Self-Taken Samples from Screening Nonattenders
por: Lam, J. U. H., et al.
Publicado: (2017)

The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study
por: Naber, Steffie K., et al.
Publicado: (2016)

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya
por: De Vuyst, H, et al.
Publicado: (2012)

Differential Detection of Human Papillomavirus Genotypes and Cervical Intraepithelial Neoplasia by Four Commercial Assays
por: Rebolj, Matejka, et al.
Publicado: (2016)

Modelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age–period–cohort approach
por: Woo, P P S, et al.
Publicado: (2005)

Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
por: Kahesa, Crispin, et al.
Publicado: (2022)

Association between human papillomavirus (HPV) DNA and micronuclei in normal cervical cytology
por: Cassel, Ana Paula Rebelo, et al.
Publicado: (2014)

Utilization of Human Papillomavirus DNA Detection for Cervical Cancer Screening in Women Presenting With Abnormal Cytology in Lokoja, Nigeria
por: Kolawole, Olatunji, et al.
Publicado: (2015)

Triaging women with human papillomavirus infection and normal cytology or low‐grade dyskaryosis: evidence from 10‐year follow up of the ARTISTIC trial cohort
por: Gilham, C, et al.
Publicado: (2019)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Human papillomavirus infection in women who develop high-grade cervical intraepithelial neoplasia or cervical cancer: a case–control study in the UK
por: Grainge, M J, et al.
Publicado: (2005)

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark—A register‐based cohort study
por: Thamsborg, Lise Holst, et al.
Publicado: (2018)

Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d’Ivoire, 2010
por: Jaquet, A, et al.
Publicado: (2012)

Results of cytology and high-risk human papillomavirus testing in females with cervical adenocarcinoma in situ
por: ANDERSSON, SONIA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ik810kg9hdg55gsda93mfheend